The RadPointer® is an advanced molecular detection probe for oncology

The RadPointer® detects emissions of local concentrations of radiopharmaceuticals, same principle as PET/SPECT, but directly in the body during the surgery in order to locate tumours, metastases and sentinel lymph nodes, and remove them with minimal damage to surrounding healthy tissues.  


  • Ultra-sensitive: detects the smallest metastases
  • No control unit
  • User-friendly
  • Miniaturized
  • Available both sterilizable and single use